Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2023-11-08 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
金陵药业股份有限公司关于召开2023年第三次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the company's 2023 third extraordinary general meeting of shareholders, including meeting time, location, voting procedures, agenda items, and proxy forms. It does not contain financial statements or results but rather logistical and procedural information for the shareholders' meeting. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is under 5,000 characters and is not an announcement of a report publication but the actual meeting notice and related materials. Therefore, the correct classification is AGM Information (AGM-R).
2023-11-08 Chinese
金陵药业股份有限公司2023年第一次独立董事专门会议审查意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from the independent directors of Jinling Pharmaceutical Co., Ltd. regarding a specific agenda item about extending the duration of an investment fund and related party transactions. It references compliance with regulatory rules and company bylaws, and it is a specialized meeting opinion rather than a full report or announcement of financial results. The document is short (661 characters) and does not contain financial statements or detailed financial data. It is not an announcement of voting results, nor a general regulatory filing, but a formal board/management related opinion. Therefore, it fits best under Board/Management Information (MANG).
2023-11-08 Chinese
金陵药业股份有限公司第九届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a specific board meeting of Jinling Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references to related announcements and independent director opinions. The content focuses on board decisions, such as extending a fund's duration and proposing a shareholders' meeting, rather than financial results or reports. The document length is short (1137 characters) and it is clearly a board meeting resolution announcement, not a full report or financial statement. Therefore, it fits best under Board/Management Information (MANG).
2023-11-08 Chinese
金陵药业股份有限公司第九届监事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the fifth meeting of the ninth Supervisory Board of Jinling Pharmaceutical Co., Ltd. It includes details about the meeting notice, attendance, voting results, and compliance with legal and regulatory requirements. The document is short (564 characters) and serves as an official announcement of a board meeting resolution rather than a full report or detailed financial disclosure. It does not contain financial statements, audit information, or management discussion. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2023-11-08 Chinese
金陵药业股份有限公司关于南京新工医疗产业投资基金合伙企业（有限合伙）延长存续期限暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the extension of the duration of a medical industry investment fund partnership and related connected transactions. It details the background, parties involved, financial data, and approvals related to the extension of the fund's term. It is a formal disclosure of a corporate action involving related-party transactions and fund management, not a financial report, earnings release, or management discussion. The document is a regulatory announcement about a corporate event involving capital investment and related party dealings, fitting best under Capital/Financing Update (CAP).
2023-11-08 Chinese
金陵药业股份有限公司独立董事关于公司第九届董事会第五次会议审议的有关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Jinling Pharmaceutical Co., Ltd. regarding a specific board meeting agenda item about extending the duration of a medical industry investment fund and related party transactions. It references compliance with company law, securities law, stock exchange listing rules, and company articles of association. The content focuses on board meeting deliberations and approval procedures, with no financial statements or earnings data. It is clearly related to board/management information about governance and decision-making at the board level rather than a full annual report, audit report, or earnings release. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and specific to board meeting matters, confirming this classification with high confidence.
2023-11-08 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.